(Q46441000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

0 references

Jean-Louis Vanoverschelde

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Sophie Goffette

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Vincent van Pesch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Emmanuel Morandini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Christian J M Sindic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

18 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

1217-1222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15834643%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-005-0839-3

10 January 2020

exact match

0 references

cites work

Cognitive change following MPTP exposure.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-005-0839-3

An open-trial evaluation of mitoxantrone in the treatment of progressive MS.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-005-0839-3

Treatment of multiple sclerosis with mitoxantrone

21 January 2018

1 reference

12 December 2020

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

1 reference

12 December 2020

Comparison of the structural changes induced by doxorubicin and mitoxantrone in the heart, kidney and intestine and characterization of the Fe(III)-mitoxantrone complex

1 reference

12 December 2020

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

1 reference

12 December 2020

Mitoxantrone immunotherapy in multiple sclerosis

1 reference

12 December 2020

Cardiac evaluation of mitoxantrone

1 reference

12 December 2020

Mitoxantrone in progressive multiple sclerosis: when and how to treat?

1 reference

12 December 2020

A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis

1 reference

12 December 2020

Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations

1 reference

12 December 2020

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

1 reference

12 December 2020

Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis

1 reference

12 December 2020

Noninvasive Assessment of Mitoxantrone Cardiotoxicity in Relapsing Remitting Multiple Sclerosis

1 reference

12 December 2020

Anthraquinone-induced cell injury: acute toxicity of carminomycin, epirubicin, idarubicin and mitoxantrone in isolated cardiomyocytes.

1 reference

12 December 2020

Mitoxantrone: an overview of safety and toxicity

1 reference

12 December 2020

Decrease in heart ventricular ejection fraction during multiple sclerosis

1 reference

12 December 2020

Anthracycline cardiotoxicity: clinical and pathologic outcomes assessed by radionuclide ejection fraction

1 reference

12 December 2020

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

1 reference

12 December 2020

Autonomic nervous system function in multiple sclerosis

1 reference

12 December 2020

Evaluation of ventricular function by echocardiography and radionuclide angiography in patients treated with mitoxantrone

1 reference

12 December 2020

Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone

1 reference

12 December 2020

Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults

1 reference

12 December 2020

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

1 reference

12 December 2020

Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.

1 reference

12 December 2020

Cardiac changes with cyclophosphamide

1 reference

12 December 2020

Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis

1 reference

12 December 2020

Anthracycline-induced cardiomyopathy

1 reference

12 December 2020